Avid Stockholders Approve Transaction with GHO and Ampersand

Group 1 - Avid Bioservices, Inc. has received stockholder approval for its transaction with GHO Capital Partners LLP and Ampersand Capital Partners [1][2] - The company anticipates closing the transaction in the coming days, as all closing conditions have been met and regulatory approvals obtained [2] - Avid Bioservices is a dedicated biologics contract development and manufacturing organization, providing a comprehensive range of services for biotechnology and biopharmaceutical industries [3] Group 2 - The company has over 30 years of experience in producing biologics, offering services that include CGMP clinical and commercial drug substance manufacturing, bulk packaging, and regulatory submissions support [3] - Avid's services range from standalone process development projects to full development and manufacturing programs through commercialization [3]